HeMemics Biotechnologies, Inc

United States - Gaithersburg, Maryland

• 26/05/2023
• Seed
• $2,000,000

Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld, lab-quality testing performance to wherever needed – whether it is a farm, emergency room or battlefield. Our rugged, low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors. Our sensors can be individually programmed to detect molecular, antigen and antibody targets. We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within minutes.

Related People

John L. Warden, Jr.Founder

United States - Chevy Chase, Maryland

Proven record of developing businesses around emerging technologies and new products. Over 25 years experience in business development, sales and capital formation of emerging technology companies.

Sales and business development executive with proven results in identifying, selling, negotiating and closing high-value agreements in pharmaceutical research, big data, chemicals and financial instruments.

LinkedIn https://www.linkedin.com/in/johnlwarden/